Banque Cantonale Vaudoise Grows Stake in HCA Healthcare, Inc. (NYSE:HCA)

Banque Cantonale Vaudoise lifted its stake in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 25.6% during the third quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 12,187 shares of the company's stock after acquiring an additional 2,481 shares during the period. Banque Cantonale Vaudoise's holdings in HCA Healthcare were worth $4,953,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in HCA. MFA Wealth Advisors LLC bought a new position in shares of HCA Healthcare during the 2nd quarter worth about $27,000. Unique Wealth Strategies LLC bought a new stake in shares of HCA Healthcare during the second quarter valued at approximately $28,000. Bangor Savings Bank increased its stake in HCA Healthcare by 112.5% in the second quarter. Bangor Savings Bank now owns 85 shares of the company's stock valued at $27,000 after acquiring an additional 45 shares during the period. GPS Wealth Strategies Group LLC lifted its stake in HCA Healthcare by 284.0% during the second quarter. GPS Wealth Strategies Group LLC now owns 96 shares of the company's stock worth $31,000 after purchasing an additional 71 shares during the period. Finally, Capital Performance Advisors LLP acquired a new position in shares of HCA Healthcare in the 3rd quarter worth approximately $41,000. Institutional investors and hedge funds own 62.73% of the company's stock.

HCA Healthcare Stock Performance

HCA traded down $2.11 during trading on Wednesday, hitting $333.00. 1,426,476 shares of the company traded hands, compared to its average volume of 1,189,091. The company has a quick ratio of 1.00, a current ratio of 1.12 and a debt-to-equity ratio of 48.71. The firm has a market cap of $84.35 billion, a P/E ratio of 14.95, a price-to-earnings-growth ratio of 1.32 and a beta of 1.68. HCA Healthcare, Inc. has a one year low of $245.84 and a one year high of $417.14. The stock's fifty day moving average is $381.99 and its 200 day moving average is $358.12.

HCA Healthcare Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Investors of record on Friday, December 13th will be issued a $0.66 dividend. This represents a $2.64 annualized dividend and a yield of 0.79%. The ex-dividend date of this dividend is Friday, December 13th. HCA Healthcare's dividend payout ratio (DPR) is presently 11.85%.

Analyst Upgrades and Downgrades

HCA has been the topic of several recent analyst reports. StockNews.com downgraded HCA Healthcare from a "strong-buy" rating to a "buy" rating in a report on Monday, November 4th. Leerink Partners upped their price target on shares of HCA Healthcare from $367.00 to $396.00 and gave the stock an "outperform" rating in a research report on Wednesday, July 24th. Truist Financial increased their price target on shares of HCA Healthcare from $390.00 to $430.00 and gave the company a "buy" rating in a research note on Monday, August 19th. UBS Group upped their price objective on HCA Healthcare from $405.00 to $438.00 and gave the stock a "buy" rating in a report on Wednesday, August 14th. Finally, KeyCorp cut their price target on HCA Healthcare from $475.00 to $420.00 and set an "overweight" rating on the stock in a research note on Monday, October 28th. Five investment analysts have rated the stock with a hold rating, thirteen have issued a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average price target of $385.00.

Insider Transactions at HCA Healthcare

In other news, SVP Phillip G. Billington sold 3,897 shares of the company's stock in a transaction on Thursday, November 14th. The shares were sold at an average price of $350.00, for a total value of $1,363,950.00. Following the completion of the sale, the senior vice president now owns 52,702 shares of the company's stock, valued at approximately $18,445,700. This represents a 6.89 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Erol R. Akdamar sold 2,900 shares of the stock in a transaction on Thursday, November 14th. The shares were sold at an average price of $353.00, for a total transaction of $1,023,700.00. Following the sale, the insider now directly owns 6,843 shares of the company's stock, valued at $2,415,579. The trade was a 29.76 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 15,155 shares of company stock valued at $5,608,990 over the last three months. Company insiders own 1.70% of the company's stock.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.